Novo Nordisk Partners with Hims & Hers: Can Turning a Foe into a Friend Reverse the Downturn? Mar 13, 2026 Life Science
Why Microsoft Is a Safe Bet in the AI Era, Despite Moderate Stock Gains Mar 13, 2026 Life Science, Technology
Seeking a Bottom in Choppy Markets? Two Long-Term Picks with “Anti-Fragile” Qualities Mar 12, 2026 Life Science, Technology
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Mar 11, 2026 Life Science
This Stock Soared 1600% in a Year! Billionaire Cohen Had Already Positioned Himself Mar 11, 2026 Life Science
A Tenfold Increase in a Decade? What Makes This Small Biotech Company So Special Mar 10, 2026 Life Science
Novo Nordisk’s Price Cuts and R&D Progress Go Hand in Hand, GLP-1 Drug Prices Reduced by Up to 50% Mar 10, 2026 Life Science
$70 Billion and Counting: The 5 US Dividend Giants That Keep on Giving Mar 9, 2026 Energy, Financial Service, Life Science, Technology
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
Clinical Data Optimism Combined with Analyst Recommendation Drives Shattuck Labs Shares Up 53% This Week Mar 6, 2026 Life Science
A Dividend Yield of Up to 4% and 48 Consecutive Years of Increases, Watch These Two Healthcare Giants Mar 6, 2026 Life Science
Institutional Buying of PTC Therapeutics Attracts Attention, How Should Retail Investors Position Themselves? Mar 4, 2026 Life Science
Why These Dow Giants Are the New Go-To for Retirement Income Mar 3, 2026 Consumer Goods, Energy, Life Science